Scleral Lens Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The scleral lens market is segmented by Type (Corneo-Scleral Lenses and Semi-Scleral Lenses, Mini-Scleral Lenses, and Full Scleral Lenses), Application (Irregular Cornea, Ocular Surface Disease, Refractive Error, and Other Applications), End User (Hospitals, Eye Clinics, and Other End Users), and Geography (North America, Europe, Asia-Pacific and Rest of World). The report offers the value (in USD million) for the above segments.

Market Snapshot

Scleral Lens Market Forecast
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 4.2 %
Scleral Lens Market Companies

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The scleral lens market is expected to register a CAGR of 4.2% over the forecast period, 2022-2027.

The emergence of the COVID-19 pandemic harmed the world economy and the healthcare system. The lockdown around the globe has affected the supply chain of pharmaceuticals, medical devices, and biotechnological products. On the other hand, R&D has come into focus. All the government agencies and healthcare players have come forward to support the development of diagnostics and treatment methods for COVID-19. In the case of scleral lenses, a survey conducted by Euro lens Research (University of Manchester) in April 2020 found that 75% of scleral lens wearers reported reductions in the use of these lenses due to lockdowns and the limited supply of daily/weekly-wear lenses. Furthermore, the major market players, such as Bausch + Lomb, Visionary Optics & AccuLens, showed declining sales owing to decreased operations. This led prominent as well as emerging companies to change their business strategies to adapt. Thus, the scleral lens market shows a negative growth impact in pandemic due to a continuous decrease in sales of the key players.

Scleral lenses are used to correct vision defects such as myopia, irregular cornea, ocular surface disease, refractive error, hyperopia, astigmatism, and presbyopia. The increase in the prevalence of this disease is expected to drive the scleral lens market over the forecast period. As per the World Health Organization, the prevalence of myopia is highest in East Asian countries such as Japan, South Korea, a, and Singapore. As per the National Center for Biotechnology Information article published in 2019, by 2050, myopia and high myopia are both expected to affect ~4,949 million and ~925 million people, respectively, globally. The growing cases of myopia and increasing spending on ophthalmic products, such as scleral lenses, as a corrective measure for refractive errors, are expected to drive the growth of the scleral lenses market in the future.

With a huge population base, developing countries worldwide, including Mexico, BRIC, India, China and South Africa, offers potential growth opportunities for contact lens manufacturers. As China and India has the highest population as compared to other countries; this countries are generating need for scleral wear due to increasing eye defects owing to the increasing geriatric population in the region. The geriatric population is estimated to increase from 548 million in 2019 to nearly 1.3 billion by 2050, that would drive the prevalence of age-related eye diseases in the region. Rising awareness of eye disorders, changing lifestyles, growing per capita spending, and market saturation in emerging economies are also encouraging market players to expand their presence in these emerging economies.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, careless usage could harm eyesight and a lack of well-equipped practitioners are likely to impede the market growth.

Scope of the Report

Scleral contacts are large-diameter gas permeable contact lenses specially designed to vault over the entire corneal surface and rest on the sclera. These lenses functionally replace the irregular cornea with a perfectly smooth optical surface to correct vision problems caused by keratoconus and other corneal irregularities. The scleral lens market is segmented by Type (Corneo-Scleral Lenses and Semi-Scleral Lenses, Mini-Scleral Lenses, and Full Scleral Lenses), Application (Irregular Cornea, Ocular Surface Disease, Refractive Error, and Other Applications), End User (Hospitals, Eye Clinics, and Other End Users), and Geography (North America, Europe, Asia-Pacific and Rest of World). The report offers the value (in USD million) for the above segments.

By Type
Corneo-scleral and Semi–scleral Lenses
Mini-Scleral Lenses
Full Scleral Lenses
By Application
Irregular Cornea
Ocular Surface Disease
Refractive Error
Other Applications
By End User
Hospitals
Eye Clinics
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Corneo-scleral and Semi–scleral Lenses Segment is Expected to Dominate the Market

The Corneo-scleral and Semi–scleral Lenses segment holds a significant market share. The corneo-scleral lens has been developed to fill the void left by both soft and rigid contact lenses. Corneo-scleral and semi–scleral Lenses offer a high level of comfort comparable to soft contact lenses and the better acuity associated with rigid lenses. By utilizing a diameter of between 14 mm and 15 mm, the same principles of minimal movement and lid interaction associated with soft contact lenses apply. The large overall diameter is advantageous in terms of comfort because the edge of the lens is tucked under both the upper and lower lids. Thus, the more sensitive lid margins are not in direct contact with the edge of the lens, which eliminates one of the greatest causes of foreign body sensation found with Rigid gas-permeable (RGP) lenses. Thus, all these advantages are fueling the growth of the product.

The increasing corneal transplantation is boosting the growth of the market. For instance, As per the National Center for Biotechnology Information survey published in 2020 on 'Corneal transplantation' approximately 185,000 of these procedures were performed worldwide each year, 34% of which were in the United States. The Corneo-scleral lenses represent a novel treatment option for patients who have undergone corneal transplantation due to the advantages offered by them. The Corneo-Scleral Lenses are also used for the eyes that have undergone a cornea transplant, and for people with severe dry eyes caused by conditions such as Sjogren's syndrome, graft-versus-host disease (GVHD) and Stevens-Johnson syndrome as the larger diameter of a corneo-scleral lens are able to eliminate all of these possibilities more effectively. The larger diameter also provides a broader area of lens alignment and much improved lens stability on an irregular corneal surface.

Additionally, the increasing cases of 'Dry eyes' are further propelling the growth of the market. For instance, as per the review of cornea & contact lenses published in 2020 dry eyes are a common condition in the United States. Most often, people who have dry eyes are middle-aged or older. An estimated 4.88 million Americans age 50 and older have dry eyes. Thus, the increasing cases of dry eyes is expected to drive the growth of the market.

Scleral Lens Market Trends

North America is Expected to Dominate the Scleral Lens Market

North America is expected to hold the major share in the global scleral lenses market. The United States is one of the key countries in the scleral lenses market, due to the higher prevalence of eye diseases and injuries that are primarily driving the growth. For instance, as per the National Eye Institute, around 12 million United States residents were detected with low vision in 2022. The number is projected to increase further and is estimated to reach around 50 million by the year 2030. Additionally, as per a report by the Centre for Disease Control and Prevention, around 54 million wearers of scleral lenses were aged 18 or older, accounting for about 22.1% of the adult population in the United States in 2019. This increase is anticipated to drive the growth of scleral lenses in the country over the forecast period.

Furthermore, the increasing research & development activities, partnerships, and novel launches by key players are responsible for the growth of the market in the region. For instance, in February 2021, Johnson & Johnson Vision, a division of Johnson & Johnson Services, announced the release of the TECNIS Toric II 1-Piece Intraocular Lens in the United States. Also, Johnson & Johnson has paid an estimated USD 4 billion for Abbott Medical Optics. The acquisition includes ophthalmic products in three areas of patient care such as cataract surgery, laser refractive surgery, and consumer eye health. These product lines have joined with the ACUVUE Brand Contact Lenses business and combined the organization would operate under the brand name Johnson & Johnson Vision (J&J Vision). The acquisition gave Johnson and Johnson a competitive advantage in cataract surgery, which is one of Abbott Medical Optics' main specialties. Thus, these initiatives are boosting the market growth in the region.

Therefore, owing to the aforesaid factors the growth of the respective market is anticipated in the North America Region.

Scleral Lens Market Report

Competitive Landscape

The global scleral lens market is highly competitive and consists of certain major players in the industry such as ABB Optical Group, Bausch Health Companies Inc., Visionary Optics, Essilor, Art Optical Contact Lens, Inc., CooperVision, BostonSight, AccuLens, Inc., Tru-Form Optics, SynergEyes, Valley Contax, Capricornia and Menicon Co., Ltd. 

Recent Development

  • In November 2021, CooperVision Specialty EyeCare launched Optimized Pupil Optics (OPO) for its Onefit MED and Onefit MED+ scleral contact lenses to eye care providers (ECPs) in the United States and Canada. 
  • In October 2021, Bausch Health Companies Inc. had launched the New 28 Lens Zenlens Dx Set to meet the growing demand for gas-permeable lenses to correct vision problems associated with corneal irregularities.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Number of Ophthalmic Patients

      2. 4.2.2 Increasing Adoption of Scleral Lenses across the Globe

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Techniques

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Type

      1. 5.1.1 Corneo-scleral and Semi–scleral Lenses

      2. 5.1.2 Mini-Scleral Lenses

      3. 5.1.3 Full Scleral Lenses

    2. 5.2 By Application

      1. 5.2.1 Irregular Cornea

      2. 5.2.2 Ocular Surface Disease

      3. 5.2.3 Refractive Error

      4. 5.2.4 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Eye Clinics

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Rest of World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 ABB Optical Group

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Visionary Optics

      4. 6.1.4 Essilor

      5. 6.1.5 Art Optical Contact Lens, Inc.

      6. 6.1.6 CooperVision

      7. 6.1.7 BostonSight

      8. 6.1.8 AccuLens, Inc.

      9. 6.1.9 Tru-Form Optics

      10. 6.1.10 SynergEyes

      11. 6.1.11 Valley Contax

      12. 6.1.12 Capricornia

      13. 6.1.13 Menicon Co., Ltd.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Scleral Lens Market market is studied from 2019 - 2027.

The Global Scleral Lens Market is growing at a CAGR of 4.2% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Visionary Optics, Essilor, ABB Optical Group, Bausch Health Companies Inc., Art Optical Contact Lens, Inc. are the major companies operating in Global Scleral Lens Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!